Xichun Zhou
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2014First federal award
$2.2MFederal grants as PI11 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
11 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 8, 2024 | NIH | SBIR Phase I Field-Deployable, low-Cost Point-of-Need urine test strips for mobile quantification of SUD medication drugs and their metabolites | $293K | VITAN-BIOTECH LLC |
| Sep 22, 2023 | NIH | SBIR Phase I Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies | $219K | VITAN-BIOTECH LLC |
| Sep 22, 2023 | NIH | SBIR Phase I Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies | $219K | VITAN-BIOTECH LLC |
| Aug 1, 2020 | NIH | SBIR Phase I Plasmonic Glycan Arrays for Highly Sensitive Detection of Glycan-binding Proteins | $223K | VITAN-BIOTECH LLC |
| Jul 21, 2020 | NIH | SBIR Phase I Plasmonic Glycan Arrays for Highly Sensitive Detection of Glycan-binding Proteins | $223K | VITAN-BIOTECH LLC |
| Apr 1, 2020 | NIH | SBIR Phase I Development of safe and effective immunotherapeutics for treatment of opioid abuse and overdose | $225K | VITAN-BIOTECH LLC |
| Feb 25, 2020 | NIH | SBIR Phase I Development of safe and effective immunotherapeutics for treatment of opioid abuse and overdose | $225K | VITAN-BIOTECH LLC |
| Jul 29, 2019 | NIH | SBIR Phase I Developing high-affinity nanobodies to tumor-associated glycan antigens | $150K | VITAN-BIOTECH LLC |
| Feb 17, 2017 | NIH | SBIR Phase I High sensitive and specific, Point-of-use lateral flow strip for on-site test of cannabis intoxication | $132K | VITAN-BIOTECH LLC |
| Dec 1, 2014 | NIH | SBIR Phase I Molecularly self-assembled multi-functional DNA Origami nanostructure for safe and effective siRNA delivery | $171K | GUILD ASSOCIATES INC |
| Nov 28, 2014 | NIH | SBIR Phase I Molecularly self-assembled multi-functional DNA Origami nanostructure for safe and effective siRNA delivery | $171K | GUILD ASSOCIATES INC |
Peer ranks
Federal funding#884
Awards as PI#106
Patents#273
Companies
- GUILD ASSOCIATES INCLinked by awards · Biotech
- VITAN-BIOTECH LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.